ES8500060A1 - Un metodo de producir una solucion de insulina. - Google Patents

Un metodo de producir una solucion de insulina.

Info

Publication number
ES8500060A1
ES8500060A1 ES519533A ES519533A ES8500060A1 ES 8500060 A1 ES8500060 A1 ES 8500060A1 ES 519533 A ES519533 A ES 519533A ES 519533 A ES519533 A ES 519533A ES 8500060 A1 ES8500060 A1 ES 8500060A1
Authority
ES
Spain
Prior art keywords
insulin
solutions
hexamer
insulin preparations
stabilized insulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES519533A
Other languages
English (en)
Other versions
ES519533A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Industri AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Industri AS filed Critical Novo Industri AS
Publication of ES519533A0 publication Critical patent/ES519533A0/es
Publication of ES8500060A1 publication Critical patent/ES8500060A1/es
Expired legal-status Critical Current

Links

Classifications

    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05K—PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K13/00—Apparatus or processes specially adapted for manufacturing or adjusting assemblages of electric components
    • H05K13/06—Wiring by machine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Manufacturing & Machinery (AREA)
  • Microelectronics & Electronic Packaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

METODO DE PREPARACION DE DISOLUCIONES DE INSULINA, QUE TIENE APLICACIONES PARA EL SUMINISTRO CONTINUO DE INSULINA.CONSISTE EN DISOLVER INSULINA EN AGUA QUE CONTIENE ACIDO, AN/ADIR UNA DISOLUCION ACUOSA DE UNA SAL DE CINC IONIZADA, QUE CONTIENE IONES CINCICOS A DISPOSICION DE LA INSULINA EN CONCENTRACION MAYOR QUE 4 ZN2B/ INSULINA HEXAMERA; AN/ADIR UN AGENTE DE CONSERVACION, UN AGENTE QUE HACE LA DISOLUCION ISOTONICA UN TAMPON Y UN AGENTE FORMADOR DE COMPLEJOS CON EL CINC.
ES519533A 1982-02-05 1983-02-04 Un metodo de producir una solucion de insulina. Expired ES8500060A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK49182 1982-02-05

Publications (2)

Publication Number Publication Date
ES519533A0 ES519533A0 (es) 1984-10-16
ES8500060A1 true ES8500060A1 (es) 1984-10-16

Family

ID=8094159

Family Applications (1)

Application Number Title Priority Date Filing Date
ES519533A Expired ES8500060A1 (es) 1982-02-05 1983-02-04 Un metodo de producir una solucion de insulina.

Country Status (22)

Country Link
US (1) US4476118A (es)
JP (1) JPS58192818A (es)
AT (1) AT382780B (es)
AU (1) AU549981B2 (es)
BE (1) BE895832A (es)
CA (1) CA1203476A (es)
CH (1) CH657530A5 (es)
DE (1) DE3303860A1 (es)
ES (1) ES8500060A1 (es)
FI (1) FI78616C (es)
FR (1) FR2521009B1 (es)
GB (1) GB2114573B (es)
GR (1) GR77388B (es)
IE (1) IE54548B1 (es)
IT (1) IT1178455B (es)
LU (1) LU84632A1 (es)
NL (1) NL187269C (es)
NO (1) NO161204C (es)
NZ (1) NZ203189A (es)
PT (1) PT76195B (es)
SE (1) SE460948B (es)
ZA (1) ZA83742B (es)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3576120D1 (de) * 1984-06-09 1990-04-05 Hoechst Ag Insulinzubereitungen, verfahren zu deren herstellung und deren verwendung.
JP2520262B2 (ja) * 1987-08-21 1996-07-31 春幸 川原 パツチテスト材料
US4789660A (en) * 1987-09-10 1988-12-06 American Home Products Corporation Insulin administration using methyl and propyl paraben
US5130298A (en) * 1989-05-16 1992-07-14 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
US5534488A (en) * 1993-08-13 1996-07-09 Eli Lilly And Company Insulin formulation
US5474978A (en) * 1994-06-16 1995-12-12 Eli Lilly And Company Insulin analog formulations
AR002976A1 (es) * 1995-03-31 1998-05-27 Lilly Co Eli Formulaciones farmaceuticas parenterales de efecto prolongado de insulina; cristales de dichos analogos aplicables en dichas formulaciones yprocedimiento de las formulaciones mencionadas
DK0861089T3 (da) * 1995-11-13 2002-10-07 Medtronic Minimed Inc Metoder og sammensætninger til indgivelse af monomere proteiner
JP2000507812A (ja) * 1996-03-12 2000-06-27 ライフ テクノロジーズ，インコーポレイテッド 造血細胞培養栄養補充成分
EP0821006B1 (de) * 1996-07-26 2004-04-21 Aventis Pharma Deutschland GmbH Insulinderivate mit erhöhter Zinkbindung
ZA984697B (en) * 1997-06-13 1999-12-01 Lilly Co Eli Stable insulin formulations.
SI0884053T1 (en) * 1997-06-13 2003-02-28 Eli Lilly And Company Stable insulin formulations
EP1028706B1 (en) * 1997-11-12 2003-07-09 Alza Corporation Buffered drug formulations for transdermal electrotransport delivery
DE19825447A1 (de) 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh Neue Insulinanaloga mit erhöhter Zinkbildung
AU758146B2 (en) * 1998-10-16 2003-03-13 Novo Nordisk A/S Stable concentrated insulin preparations for pulmonary delivery
DE19930676B4 (de) * 1999-07-02 2006-01-19 Sanofi-Aventis Deutschland Gmbh Verfahren zur Stabilisierung von Insulin, Insulinderivaten und/oder deren Vorläufer in komplexen Mischungen bei deren Lagerung in wäßrigen Lösungsmitteln
EP1265630B1 (en) * 2000-03-24 2006-06-07 Genentech, Inc. Use of insulin for the treatment of cartilagenous disorders
JP4147234B2 (ja) * 2004-09-27 2008-09-10 キヤノン株式会社 吐出用液体、吐出方法、カートリッジ及び吐出装置
DE60335797D1 (de) 2002-05-07 2011-03-03 Novo Nordisk As Lösliche formulierungen, die monomeres insulin und acyliertes insulin enthalten
US20050065066A1 (en) * 2002-12-20 2005-03-24 Kaarsholm Niels Christian Stabilised insulin compositions
AU2003291972A1 (en) * 2002-12-20 2004-07-14 Novo Nordisk A/S Pharmaceutical compositions comprising insulin and legends of insulin hexamer
WO2004096266A1 (en) * 2003-05-02 2004-11-11 Novo Nordisk A/S Improved physical stability of insulin formulations
AU2004261353B2 (en) * 2003-08-05 2009-12-10 Novo Nordisk A/S Novel insulin derivatives
PT2626368T (pt) 2004-07-19 2017-03-10 Biocon Ltd Conjugados de insulina-oligómero, formulaçôes e usos dos mesmos
ATE519780T1 (de) * 2005-12-28 2011-08-15 Novo Nordisk As Ein acyliertes insulin und zink enthaltende zusammensetzungen und verfahren zur herstellung dieser zusammensetzungen
US20090136538A1 (en) * 2006-05-22 2009-05-28 Jan Jezek Stable vaccine formulation
GB0700523D0 (en) * 2007-01-11 2007-02-21 Insense Ltd The Stabilisation Of Proteins
ES2841379T3 (es) 2007-03-13 2021-07-08 Jds Therapeutics Llc Procedimientos y composiciones para la liberación sostenida de cromo
WO2008152106A1 (en) * 2007-06-13 2008-12-18 Novo Nordisk A/S Pharmaceutical formulation comprising an insulin derivative
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
CN101861333A (zh) * 2007-11-16 2010-10-13 诺沃-诺迪斯克有限公司 包含glp-1肽或毒蜥外泌肽-4和基础胰岛素肽的药物组合物
EP2341940A1 (en) * 2008-07-16 2011-07-13 Arecor Limited The stabilisation of proteins
EP2328607A1 (en) * 2008-07-16 2011-06-08 Arecor Limited Stable formulation of a therapeutic protein
KR20110085985A (ko) * 2008-10-30 2011-07-27 노보 노르디스크 에이/에스 하루 한번 주사 빈도보다 적은 인슐린 주사를 사용한 진성 당뇨병의 치료
US9060927B2 (en) 2009-03-03 2015-06-23 Biodel Inc. Insulin formulations for rapid uptake
JP6049625B2 (ja) 2010-10-27 2016-12-21 ノヴォ ノルディスク アー／エス 様々な注射間隔を用いて施されるインスリン注射を使用する、真性糖尿病の治療
AU2012223282B2 (en) 2011-03-01 2017-02-02 Nutrition 21, Llc Compositions of insulin and chromium for the treatment and prevention of diabetes, hypoglycemia and related disorders
MX360107B (es) 2012-11-13 2018-10-23 Adocia Formulación de acción rápida de insulina que comprende un compuesto aniónico sustituido.
RU2015129087A (ru) 2012-12-19 2017-02-02 Вокхардт Лимитед Стабильная водная композиция, содержащая инсулин человека или его аналог или производное
CN104870469A (zh) 2012-12-26 2015-08-26 沃克哈特有限公司 药物组合物
TWI641381B (zh) * 2013-02-04 2018-11-21 法商賽諾菲公司 胰島素類似物及／或胰島素衍生物之穩定化醫藥調配物
EP2991672A1 (en) 2013-04-30 2016-03-09 Novo Nordisk A/S Novel administration regime
WO2015084694A2 (en) * 2013-12-04 2015-06-11 Merck Sharp & Dohme Corp. Method for preparing crystalline insulin
AR102869A1 (es) 2014-12-16 2017-03-29 Lilly Co Eli Composiciones de insulina de rápida acción
JO3749B1 (ar) 2015-08-27 2021-01-31 Lilly Co Eli تركيبات إنسولين سريعة المفعول
EP3413900A1 (en) 2016-02-11 2018-12-19 Nutrition 21, LLC Chromium containing compositions for improving health and fitness
EP3518893A1 (en) * 2016-09-29 2019-08-07 Arecor Limited Novel formulations
NZ758298A (en) 2017-06-01 2022-11-25 Lilly Co Eli Rapid-acting insulin compositions
US10335464B1 (en) 2018-06-26 2019-07-02 Novo Nordisk A/S Device for titrating basal insulin

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2882202A (en) * 1950-04-05 1959-04-14 Novo Terapeutisk Labor As Insulin crystal preparations and methods of producing them
US2787575A (en) * 1950-11-22 1957-04-02 Organon Zinc-glycine-insulin composition and production thereof
US2882203A (en) * 1951-06-26 1959-04-14 Novo Terapeutisk Labor As Injectable insulin preparation with protracted effect
DE1044360B (de) * 1953-08-19 1958-11-20 Roskilde Medical Company Ltd R Verfahren zur Herstellung von Zinkinsulin mit erhoehtem Zinkgehalt
DE956098C (de) * 1954-02-18 1957-01-10 Dr Dr Guenther Weitzel Verfahren zur Herstellung zinkreicher Insulin-Komplexverbindungen
US3058885A (en) * 1957-06-08 1962-10-16 Novo Terapeutisk Labor As Process for treatment of insulin crystals and for production of insulin preparationstherefrom
US3014842A (en) * 1957-08-10 1961-12-26 Novo Terapeutish Lab A S Injectable bovine insulin crystal suspensions and process of producing same
US3091573A (en) * 1958-05-12 1963-05-28 Novo Terapeutisk Labor As Quick acting insulin preparation
FR1263220A (fr) * 1958-08-01 1961-06-09 Novo Terapeutisk Labor As Procédé de production d'une préparation d'insuline à action rapide
DK116527B (da) * 1967-03-01 1970-01-19 Nordisk Insulinlab Fremgangsmåde til fremstilling af en hurtigtvirkende, holdbar, neutral opløsning af rent krystallinsk okseinsulin eller okseinsulin, der ved tilsætning af Zn er krystalliserbart i vand, eller blandinger af okseinsulin og insulin af anden oprindelse.
GB1285023A (en) * 1968-08-09 1972-08-09 Novo Terapeutisk Labor As Improvements in or relating to injectable insulin preparations
US3657425A (en) * 1969-03-12 1972-04-18 Burroughs Wellcome Co Beef insulin preparations
EP0018609B1 (de) * 1979-04-30 1983-09-21 Hoechst Aktiengesellschaft Gegen Denaturierung beständige, wässrige Protein-Lösungen, Verfahren zu ihrer Herstellung und ihre Verwendung
DK80781A (da) * 1980-02-29 1981-08-30 Hospital For Sick Children Oploesninger af polypeptider
WO1983003054A1 (en) * 1982-03-03 1983-09-15 Johansen, Kristian, Betton A proces for producing an insulin preparation

Also Published As

Publication number Publication date
AT382780B (de) 1987-04-10
ATA38983A (de) 1986-09-15
NL8300440A (nl) 1983-09-01
IT1178455B (it) 1987-09-09
GB8303133D0 (en) 1983-03-09
GR77388B (es) 1984-09-11
IE830220L (en) 1983-08-05
ES519533A0 (es) 1984-10-16
NZ203189A (en) 1985-07-31
BE895832A (fr) 1983-08-04
AU549981B2 (en) 1986-02-20
NO161204B (no) 1989-04-10
US4476118A (en) 1984-10-09
IE54548B1 (en) 1989-11-08
FR2521009A1 (fr) 1983-08-12
FR2521009B1 (fr) 1987-07-17
ZA83742B (en) 1983-11-30
NO830385L (no) 1983-08-08
JPH0367056B2 (es) 1991-10-21
SE8300598D0 (sv) 1983-02-04
FI78616B (fi) 1989-05-31
SE460948B (sv) 1989-12-11
AU1113683A (en) 1983-08-11
NL187269C (nl) 1991-08-01
DE3303860A1 (de) 1983-08-18
NO161204C (no) 1989-07-19
IT8319420A0 (it) 1983-02-04
JPS58192818A (ja) 1983-11-10
FI78616C (fi) 1989-09-11
SE8300598L (sv) 1983-08-06
GB2114573A (en) 1983-08-24
CH657530A5 (de) 1986-09-15
GB2114573B (en) 1985-05-01
LU84632A1 (fr) 1983-09-08
CA1203476A (en) 1986-04-22
PT76195A (en) 1983-03-01
DE3303860C2 (es) 1989-12-28
FI830375L (fi) 1983-08-06
FI830375A0 (fi) 1983-02-03
NL187269B (nl) 1991-03-01
PT76195B (en) 1986-01-27

Similar Documents

Publication Publication Date Title
ES8500060A1 (es) Un metodo de producir una solucion de insulina.
IL76932A0 (en) Pharmaceutical compositions containing dihydrocodeine and ibuprofen
ES2001996A6 (es) Procedimiento para preparar composiciones farmaceuticas contra enfermedades cronicas de trasplante frente a hospedante y contra enfermedades de autoinmunidad.
FR2501507B1 (es)
EP0600532A3 (en) Use of ionic cloud point modifiers to prevent particle aggregation during sterilization.
IE862543L (en) Pharmaceutical compositions
MY101544A (en) Pharmaceutical composition for external use containing active-type vitamin d3.
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
ZA862628B (en) Method for administering insulin
AU7567587A (en) Dosage form for delivering acid sensitive beneficial agent
ZA871911B (en) New pharmaceutical preparations with extended release
AU7200387A (en) Device for self-administration of physiologically active substances, with prevention of overdosing
MY101791A (en) New benzimidazole derivatives
ZA87472B (en) System for delivering drug with enhanced bioacceptability
JPS5767518A (en) Radiosensitizing agent or agent for increasing effect of radiomimetic substance
GB2128268B (en) Delivery-regulation unit for in-line injection pumps
DE3380166D1 (en) Pharmaceutical composition containing a fibrinolytic agent and a diffusion factor, useful for the treatment of the myocardium infarction
FI884838A0 (fi) Nytt s-timololderivat och foerfarande foer dess framstaellning.
ES8704903A1 (es) Un metodo para preparar 6-cloro-2-metil-1h-2,3,4,5-tetrahidro-3-benzazepen-n-oxido.
ES8400397A1 (es) Un procedimiento para la preparacion de un nuevo peptido activo.
Zhurkov et al. Dependence of the rate of chromosome aberrations in mouse bone marrow cells on the concentration(dose) of benzene at different administration routes.
ES8206973A1 (es) Procedimiento de preparar soluciones desagregadas de poli- peptidos
BG94567A (en) Medicaments for the treatment of aids and method for its application
JO1238B1 (en) Pharmacy formulations include human insulin, human peptide-C and the human insulin component
JPS57197220A (en) Muscle relaxant